Quadratus Lumborum Block for Total Abdominal Hysterectomy
Postoperative Pain
About this trial
This is an interventional treatment trial for Postoperative Pain focused on measuring Quadratus lumborum block, Postoperative analgesia
Eligibility Criteria
Inclusion Criteria: endometrial carcinoma or uterine fibroids American society of anesthesiologists (ASA) physical status 1-3, Participant's body weight > 50 kg, Written informed consent signed. Exclusion Criteria: Patient's refusal Allergies to any study medication Local skin infection on the site of QLB injection 3. Body mass index > 40 kg/m2 4. Inability to comprehend or participate in scoring scales 4. Deformations that could possibly affect the spread of the local anesthetic in the quadratus lumborum muscle plane 5. Quadratus lumborum muscle plane not seen in ultrasound examination 6. Patients on regular use of opioids 7. Psychiatric disorders
Sites / Locations
- CCNisRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
No Intervention
QLB group
Control group
At the end of surgery, before emergence of anesthesia, participants will receive bilateral QLB and intravenous (IV) ketoprofen 100 mg. Ketoprofen 100 mg IV will be repeated every 12 hours. For breakthrough pain patients will receive an IV bolus of morphine 5 mg. IV bolus can be repeated after 20 min. The maximum is 8 boluses for 4 hours.
At the end of surgery, before emergence of anesthesia, participants will receive IV ketoprofen 100 mg. Ketoprofen 100 mg IV will be repeated every 12 hours. For breakthrough pain patients will receive an IV bolus of morphine 5 mg. IV bolus can be repeated after 20 min. The maximum is 8 boluses for 4 hours.